Status:
TERMINATED
Diverting Loop Ileostomy: With or Without Rod
Lead Sponsor:
Insel Gruppe AG, University Hospital Bern
Conditions:
Ileostomy
Rectal Neoplasms
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Diverting ileostomies are created to protect a rectal anastomosis or in situations with a risk of intestinal perforation. Currently, the application of a rod to hinder slippage of the loop is an estab...
Detailed Description
Background For rectal anastomoses within 6 cm of the anal verge, leakage rates are up to 15%. Here liberal use of protective stomas is widely accepted. Fecal diversion by loop ostomy may also be perf...
Eligibility Criteria
Inclusion
- Inclusion Criteria:
- patients scheduled for planned protective loop ileostomy
- Exclusion Criteria
- patients with long-term use of corticosteroids (\> 15 mg prednisolone equivalent)
- immunosuppressive agent rapamune
Exclusion
Key Trial Info
Start Date :
August 1 2008
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
November 1 2014
Estimated Enrollment :
121 Patients enrolled
Trial Details
Trial ID
NCT00959738
Start Date
August 1 2008
End Date
November 1 2014
Last Update
November 14 2014
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Bern University Hospital, Dep. of Visceral and Transplant Surgery
Bern, Switzerland, 3010